Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
Blood Advances
|
May 12, 2023
CD38 as a pan-hematologic target for chimeric antigen receptor T cells
Tina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, et al.
Cancer Immunology Research
|
June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
Ju-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Transplantation and Cellular Therapy
|
May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies
Rebecca A Gardner, Claire White, Magdi Elsallab, et al.
Blood Advances
|
August 24, 2022
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
Caner Saygin, Gregory Roloff, Christopher N Hahn, et al.
Nature Communications
|
June 11, 2022
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
Amanda Heard, Jack H Landmann, Ava R Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
Marco Ruella, Saad S Kenderian, Olga Shestova, et al.
European Journal of Haematology
|
December 27, 2024
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen
Margaret Rowe, Daria Babushok, Martin Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia
Noelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
Transplantation and Cellular Therapy
|
May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells
Viktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
JAMA Internal Medicine
|
October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial
Benjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
Blood Advances
|
May 12, 2023
CD38 as a pan-hematologic target for chimeric antigen receptor T cells
Tina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, et al.
Cancer Immunology Research
|
June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
Ju-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Transplantation and Cellular Therapy
|
May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies
Rebecca A Gardner, Claire White, Magdi Elsallab, et al.
Blood Advances
|
August 24, 2022
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
Caner Saygin, Gregory Roloff, Christopher N Hahn, et al.
Nature Communications
|
June 11, 2022
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
Amanda Heard, Jack H Landmann, Ava R Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
Marco Ruella, Saad S Kenderian, Olga Shestova, et al.
European Journal of Haematology
|
December 27, 2024
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen
Margaret Rowe, Daria Babushok, Martin Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia
Noelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
Transplantation and Cellular Therapy
|
May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells
Viktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
JAMA Internal Medicine
|
October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial
Benjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Page
of 10